Company
Headquarters: Tokyo, Japan
Employees: 547
CEO: Mr. Hideumi Akizawa
¥37.60 Billion
JPY as of July 1, 2025
US$262.2 Million
| Company | Market Cap (USD) |
|---|---|
| McKesson Corporation | $88.11 B |
| Cencora, Inc. | $56.44 B |
| Cardinal Health, Inc. | $38.66 B |
| Henry Schein, Inc. | $9.31 B |
| Shanghai Pharmaceuticals Holding Co. Ltd | $8.37 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Novo Nordisk | $309.91 B |
| UnitedHealth Group | $279.90 B |
WIN-Partners Co., Ltd., through its subsidiaries, distributes medical devices primarily in Japan. The company offers percutaneous transluminal coronary angioplasty balloon catheters, drug-eluting stents, and intravascular ultrasound catheters; pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters; and stent grafts, transcatheter heart valves, and mechanical heart valves. It also provides peripheral vascular stents, carotid artery stents, and neurovascular occlusion coils; and insulin pumps, X-ray angio systems, and magnetic resonance imaging equipment. The company was founded in 1973 and is headquartered in Tokyo, Japan.
WIN-Partners Co. Ltd has the following listings and related stock indices.
Stock: JPX: 3183 wb_incandescent